Group 1 - The core point of the news is that Lidman Biochemical Co., Ltd. has seen a stock price increase of 5.46%, reaching 11.39 CNY per share, with a total market capitalization of 6.196 billion CNY [1] - The company is located in Beijing Economic and Technological Development Zone and focuses on the research and production of biochemical reagents, operating 10 subsidiaries and a nationwide distribution network [1] - Lidman has a daily production capacity of 4000 liters and aims to advance biological sciences and improve the quality of life for people [1] Group 2 - As of July 31, the number of shareholders for Lidman is 17,000, with an average of 31,900 circulating shares per person [2] - For the first quarter of 2025, Lidman reported operating revenue of 78.9087 million CNY, a year-on-year decrease of 16.61%, while the net profit attributable to shareholders was -1.2517 million CNY, reflecting a year-on-year increase of 53.73% [2]
利德曼上涨5.46%,报11.39元/股